Publications
2018
In silico Prioritization of Transporter-Drug Relationships From Drug Sensitivity Screens.
César-Razquin A,
Girardi E,
Yang M,
Brehme M,
Saez-Rodriguez J,
Superti-Furga G.
Front Pharmacol. 2018 Sep 7;9:1011. doi: 10.3389/fphar.2018.01011. eCollection 2018.
2018
LZTR1 is a regulator of RAS ubiquitination and signaling.
Bigenzahn JW,
Collu GM,
Kartnig F,
Pieraks M,
Vladimer GI,
Heinz LX,
Sedlyarov V,
Schischlik F,
Fauster A,
Rebsamen M,
Parapatics K,
Blomen VA,
Müller AC,
Winter GE,
Kralovics R,
Brummelkamp TR,
Mlodzik M,
Superti-Furga G.
Science. 2018 Nov 15. pii: eaap8210. doi: 10.1126/science.aap8210. [Epub ahead of print]
2018
Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay.
Hashimoto M,
Girardi E,
Eichner R,
Superti-Furga G.
ACS Chem Biol. 2018 Jun 6. doi: 10.1021/acschembio.8b00270. [Epub ahead of print]
2018
The Bicarbonate Transporter SLC4A7 Plays a Key Role in Macrophage Phagosome Acidification.
Sedlyarov V,
Eichner R,
Girardi E,
Essletzbichler P,
Goldmann U,
Nunes-Hasler P,
Srndic I,
Moskovskich A,
Heinz LX,
Kartnig F,
Bigenzahn JW,
Rebsamen M,
Kovarik P,
Demaurex N,
Superti-Furga G.
Cell Host Microbe. 2018 Jun 13;23(6):766-774.e5. doi: 10.1016/j.chom.2018.04.013.
2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.
Skucha A,
Ebner J,
Schmöllerl J,
Roth M,
Eder T,
César-Razquin A,
Stukalov A,
Vittori S,
Muhar M,
Lu B,
Aichinger M,
Jude J,
Müller AC,
Győrffy B,
Vakoc CR,
Valent P,
Bennett KL,
Zuber J,
Superti-Furga G,
Grebien F.
Nat Commun. 2018 May 18;9(1):1983. doi: 10.1038/s41467-018-04329-y.
2018
mTOR Senses Environmental Cues to Shape the Fibroblast-like Synoviocyte Response to Inflammation.
Cell Rep. 2018 May 15;23(7):2157-2167. doi: 10.1016/j.celrep.2018.04.044.
2018
Proteogenomic Analysis to Identify Missing Proteins from Haploid Cell Lines.
Lee SE,
Song J,
Bösl K,
Müller AC,
Vitko D,
Bennett KL,
Superti-Furga G,
Pandey A,
Kandasamy RK,
Kim MS.
Proteomics. 2018 Apr;18(8):e1700386. doi: 10.1002/pmic.201700386.
2017
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.
Li J,
Casteels T,
Frogne T,
Ingvorsen C,
Honoré C,
Courtney M,
Huber KV,
Schmitner N,
Kimmel RA,
Romanov RA,
Sturtzel C,
Lardeau CH,
Klughammer J,
Farlik M,
Sdelci S,
Vieira A,
Avolio F,
Briand F,
Baburin I,
Májek P,
Pauler FM,
Penz T,
Stukalov A,
Gridling M,
Parapatics K,
Barbieux C,
Berishvili E,
Spittler A,
Colinge J,
Bennett KL,
Hering S,
Sulpice T,
Bock C,
Distel M,
Harkany T,
Meyer D,
Superti-Furga G,
Collombat P,
Hecksher-Sørensen J,
Kubicek S.
Cell. 2017 Jan 12;168(1-2):86-100.e15. doi: 10.1016/j.cell.2016.11.010. Epub 2016 Dec 1.
2017
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
Byrgazov K,
Kastner R,
Gorna M,
Hoermann G,
Koenig M,
Lucini CB,
Ulreich R,
Benesch M,
Strenger V,
Lackner H,
Schwinger W,
Sovinz P,
Haas OA,
van den Heuvel-Eibrink M,
Niemeyer CM,
Hantschel O,
Valent P,
Superti-Furga G,
Urban C,
Dworzak MN,
Lion T.
Leukemia. 2017 Jan;31(1):237-240. doi: 10.1038/leu.2016.250. Epub 2015 Aug 30. No abstract available.
2017
Next generation of network medicine: interdisciplinary signaling approaches.
Korcsmaros T,
Schneider MV,
Superti-Furga G.
Integr Biol (Camb). 2017 Feb 20;9(2):97-108. doi: 10.1039/c6ib00215c. Review.
